Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Murtaza Khorakiwala
|
| gptkbp:country |
gptkb:India
|
| gptkbp:foundedBy |
Habil Khorakiwala
|
| gptkbp:foundedYear |
1960
|
| gptkbp:hasResearchCenter |
gptkb:India
gptkb:UK |
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| https://www.w3.org/2000/01/rdf-schema#label |
Wockhardt
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:Bombay_Stock_Exchange
gptkb:National_Stock_Exchange_of_India |
| gptkbp:manufacturingFacilities |
gptkb:India
gptkb:Ireland gptkb:UK |
| gptkbp:market |
global
|
| gptkbp:notableProduct |
gptkb:Wosulin
gptkb:Erythropoietin Biovac-B |
| gptkbp:numberOfEmployees |
~7000
|
| gptkbp:products |
pharmaceuticals
biotechnology products vaccines |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:subsidiary |
Wockhardt Bio AG
Wockhardt UK Ltd |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.wockhardt.com/
|
| gptkbp:bfsParent |
gptkb:Wosulin
gptkb:Bandra_Kurla_Complex |
| gptkbp:bfsLayer |
7
|